146 related articles for article (PubMed ID: 3241323)
21. [A nationwide study of the antimicrobial susceptibility of clinical isolates of Escherichia coli in Japan].
Igari J; Shitara M; Morimoto M; Shiga N; Kosakai N
Jpn J Antibiot; 1986 Nov; 39(11):3094-109. PubMed ID: 3546776
[TBL] [Abstract][Full Text] [Related]
22. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1989). I. Susceptibility distribution].
Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
Jpn J Antibiot; 1995 Sep; 48(9):1131-60. PubMed ID: 7474333
[TBL] [Abstract][Full Text] [Related]
23. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1996)].
Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Shimizu Y; Terai T; Inoue H; Nakadate T; Ito C; Yoshida T; Ohno I; Tanno Y; Arakawa M; Igarashi K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Nakata K; Nakatani T; Inagawa H; Kusano N
Jpn J Antibiot; 1998 Jul; 51(7):437-74. PubMed ID: 9755430
[TBL] [Abstract][Full Text] [Related]
24. [Comparison of in vitro activities of first, second and third generation cephem antibiotics against various pathogens isolated from clinical material in 1985].
Matsuo K; Tsuzaki Y; Furukawa S; Uete T
Jpn J Antibiot; 1986 Oct; 39(10):2579-86. PubMed ID: 3100836
[TBL] [Abstract][Full Text] [Related]
25. Combination chemotherapy for infections due to methicillin-resistant Staphylococcus aureus with combination therapy by cefuzonam and fosfomycin or minocycline in the urologic field.
Matsumoto T; Kubo S; Haraoka M; Takahashi K; Tanaka M; Sakumoto M; Kumazawa J
Clin Ther; 1993; 15(5):819-28. PubMed ID: 8269448
[TBL] [Abstract][Full Text] [Related]
26. [Antibacterial activity of norfloxacin on methicillin-resistant Staphylococcus aureus. Comparison with oral antibacterial agents].
Iwata S; Kawashima C; Sakamoto H; Isohata E; Kin Y; Yokota T; Kusumoto Y; Sato Y; Akita H; Oikawa T
Jpn J Antibiot; 1990 Feb; 43(2):228-32. PubMed ID: 2362350
[TBL] [Abstract][Full Text] [Related]
27. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1993). I. Susceptibility distribution].
Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Tazaki H; Iri H
Jpn J Antibiot; 1995 Nov; 48(11):1757-87. PubMed ID: 8558757
[TBL] [Abstract][Full Text] [Related]
28. [In vitro susceptibility of Escherichia coli and Klebsiella sp. to antibiotics].
Igari J; Shitara M; Shitara M; Yoshimoto K; Hayashi Y
Jpn J Antibiot; 1990 Apr; 43(4):659-69. PubMed ID: 2199690
[TBL] [Abstract][Full Text] [Related]
29. [Comparison of sensitivity patterns of bacteria isolated from clinical materials to the 2d generation cephamycins and cephalosporins and clinical application of these antibiotics].
Matsuo K; Uete T
Jpn J Antibiot; 1983 Jul; 36(7):1621-37. PubMed ID: 6317908
[TBL] [Abstract][Full Text] [Related]
30. [A nationwide study of the antimicrobial susceptibility of clinical isolates of Klebsiella sp. in Japan].
Igari J; Shitara M; Morimoto M; Shiga N; Kosakai N
Jpn J Antibiot; 1986 Nov; 39(11):3110-24. PubMed ID: 3469423
[TBL] [Abstract][Full Text] [Related]
31. Sensitivity of Staphylococcus aureus and Streptococcus pyogenes isolated from skin infections in 1992 to antimicrobial agents.
Nishijima S; Namura S; Kawai S; Akamatsu H; Asada Y; Kawabata S
J Dermatol; 1994 Apr; 21(4):233-8. PubMed ID: 8056894
[TBL] [Abstract][Full Text] [Related]
32. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1987). I. Susceptibility distribution].
Kosakai N; Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Yoshida H; Ogata M; Tazaki H
Jpn J Antibiot; 1990 Jun; 43(6):919-53. PubMed ID: 2122040
[TBL] [Abstract][Full Text] [Related]
33. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1994). I. Susceptibility distribution].
Kumamoto Y; Hirose T; Yokoo A; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Tazaki H; Iri H; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Kitagawa R; Igari J; Oguri T; Kosakai N; Yamaguchi K; Kashitani F; Yonezu S; Yamanaka Y; Takaha M; Iori F
Jpn J Antibiot; 1996 May; 49(5):465-93. PubMed ID: 8752862
[TBL] [Abstract][Full Text] [Related]
34. [Antibiotic susceptibility of bacteria isolated from surgical infections (first report)].
Yura J; Shinagawa N; Ishikawa S; Hayasaka H; Shiramatsu K; Ishibiki K; Aikawa N; Suzuki H; Takahashi T; Sakai K
Jpn J Antibiot; 1986 Oct; 39(10):2557-78. PubMed ID: 3543430
[TBL] [Abstract][Full Text] [Related]
35. [Antibacterial activities and electron microscopic studies of imipenem in combination with fosfomycin against methicillin and fosfomycin resistant strains of Staphylococcus aureus].
Saionji K; Shitara S; Kobayashi I
Jpn J Antibiot; 1990 Mar; 43(3):379-87. PubMed ID: 2374289
[TBL] [Abstract][Full Text] [Related]
36. [Surveillance of susceptibility of clinical isolates to cefmetazole between 2000 and 2002].
Abe T; Sato Y; Sei M
Jpn J Antibiot; 2003 Dec; 56(6):574-83. PubMed ID: 15007873
[TBL] [Abstract][Full Text] [Related]
37. [Laboratory and clinical studies of cefmetazole in serious infection by Staphylococcus (author's transl)].
Motohiro T; Sakata Y; Fujimoto T; Nishiyama T; Ishimoto K; Tominaga K; Yamashita F; Onoda Y; Kusayanagi T; Tsuboi M; Toubo Y; Yamamoto M; Komatsu R; Tanaka C; Baba Y
Jpn J Antibiot; 1982 Mar; 35(3):821-34. PubMed ID: 6954289
[TBL] [Abstract][Full Text] [Related]
38. [Susceptibility of bacteria isolated from lower respiratory tract infections to antibiotics (1983)].
Ikemoto H; Watanabe K; Kosakai N; Hayashi Y; Oguri T; Saito A; Shinohara M; Matsumiya H; Ueda K; Ida S
Jpn J Antibiot; 1985 Nov; 38(11):3119-44. PubMed ID: 3937915
[TBL] [Abstract][Full Text] [Related]
39. [Annual changes in isolation of MRSA in our department and chemotherapeutic effect of antibiotics including minocycline against postoperative infections of methicillin-resistant S. aureus].
Yokoyama T; Kodama T; Takesue Y; Fujimoto M; Murakami Y; Sewake H; Imamura Y; Okita M
Jpn J Antibiot; 1990 Jan; 43(1):131-8. PubMed ID: 2348549
[TBL] [Abstract][Full Text] [Related]
40. [Fundamental and clinical studies on cefuzoname in the pediatric field].
Toyonaga Y; Sugita M; Kawamura K; Seo K; Takahashi T; Hori M
Jpn J Antibiot; 1987 Apr; 40(4):843-65. PubMed ID: 3613094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
